Concepedia

Narges Khaghanzadeh

NK

5

Publications

120

Citations

5

H-Index

2009

Active since

Affiliations

Shiraz University of Medical Sciences(Current)

Mashhad University of Medical Sciences

Narges Khaghanzadeh is an author at Shiraz University of Medical Sciences specializing in oncology, cancer genetics, and lung cancer.

ORCID

Top concepts

Publications per year

2009–2017

5

Publications

5

Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells

Narges Khaghanzadeh, Zahra Mojtahedi, Mohammad Ramezani et al. · DARU Journal of Pharmaceutical Sciences · 2012 · 39 citations · Full text

CTLA4 gene variations and haplotypes in patients with lung cancer

Narges Khaghanzadeh, Nasrollah Erfani, Seiyed Mohammad Ali Ghayumi et al. · Cancer Genetics and Cytogenetics · 2009 · 31 citations

, , +9

Umbelliprenin induced production of IFN-<b>γ</b>and TNF-<b>α</b>, and reduced IL-10, IL-4, Foxp3 and TGF-<b>β</b>in a mouse model of lung cancer

Narges Khaghanzadeh, Afshin Samiei, Mohammad Ramezani et al. · Immunopharmacology and Immunotoxicology · 2013 · 27 citations

PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases.

Alamtaj Samsami Dehaghani, Mohammad Amin Kashef, Mehdi Ghaemenia et al. · PubMed · 2009 · 13 citations

Umbelliprenin induced both anti-inflammatory and regulatory cytokines in C57/BL6 mice.

Narges Khaghanzadeh, Afshin Samiei, Zahra Mojtahedi et al. · PubMed · 2017 · 10 citations · Full text

Rows per page

1–5 of 5